Regulation of calcium homeostasis during pregnancy is complex. Clinically significant bone mass loss is infrequent; however a subset of women may develop symptomatic osteoporosis related to pregnancy. Lactation is a period of special risk for bone loss. Whatever the effect of heparin on bone loss, vertebral fractures are rare in women treated with heparin during pregnancy. Low molecular weight heparins may have a less deleterious effect on bone than unfractionated heparin. Women with autoimmune diseases, particularly those with lupus and/or the antiphospholipid syndrome may receive heparin throughout pregnancy. Corticosteroids must be reduced as much as possible in these women, and calcium plus vitamin D are recommended. Finally, indications for heparin use must be clearly justified and advice regarding breastfeeding must be offered.
Khamashta MA , Cuadrado MJ , Mujic F , Taub NA , Hunt BJ , Hughes GRV . The management of thrombosis in the antiphospholipid-antibody syndrome . New Engl J Med1995; 332: 993–997 .
2.
Ruiz-Irastorza G , Khamashta MA , Hughes GRV . Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes syndrome . Lupus2001; 10: 241–245 .
3.
Ruiz-Irastorza G , Khamashta MA , Hughes GR . Systemic lupus erythematosus and antiphospholipid syndrome during pregnancy: maternal and fetal complications and their management . Isr Med Assoc J2000; 2: 462–469 .
4.
Weitz JI . Low-molecular-weight heparins . New Engl J Med1997; 337: 688–698 .
5.
Eriksen EF . Calcium metabolism during pregnancy and lactation . Scand J Rheumatol1998; 27(Suppl 107): 63-63 .
Black AJ , Topping J , Durham B , Farquharson RG , Fraser WD . A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy . J Bone Miner Res2000; 15: 557–563 .
9.
Smith R , Athanasou NA , Ostlere SJ , Vipond SE . Pregnancy-associated osteoporosis . Q J Med1995; 88: 865–878 .
10.
Phillips AJ , Ostlere SJ , Smith R . Pregnancy-associated osteoporosis: does the skeleton recover?Osteoporosis Int2000; 11: 449–454 .
11.
Muir JM , Andrew M , Hirsh J et al. Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo . Blood1996; 88: 1314–1320 .
12.
Shaughnessy SG , Hirsh J , Bhandari M , Muir JM , Young E , Weitz JI . A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in rats . Blood1999; 93: 1231–1236 .
13.
Ginsberg JS , Greer I , Hirsh J . Use of antithrombotic agents during pregnancy . Chest2001; 119: 122S–131S .
14.
Monreal M , Lafoz E , Olive A , del Rio L , Vedia C . Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin1 in patients with venous thromboembolism and contraindications to coumarin . Thromb Haemost1994; 71: 7–11 .
15.
Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin . Am J Obstet Gynecol1993; 168: 1265–1270 .
16.
Ginsberg JS , Kowalchuk G , Hirsh J et al. Heparin effect on bone density . Thromb Haemost1990; 64: 286–289 .
17.
Douketis JD , Ginsberg JS , Burrows RF , Duku EK , Webber CE , Brill-Edwards P . The effects of long-term heparin therapy during pregnancy on bone density: a prospective matched controlled study . Thromb Haemost1996; 75: 254–257 .
18.
Barbour LA , Kick SD , Steiner JF et al. A prospective study of heparininduced osteoporosis in pregnancy using bone densitometry . Am J Obstet Gynecol1994; 170: 862–869 .
19.
Dahlman TC , Sjöeberg HE , Ringertz H . Bone mineral density during long-term prophylaxis with heparin in pregnancy . Am J Obstet Gynecol1994; 170: 1315–1320 .
20.
Rai R , Cohen H , Dave M , Regan L . Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) . Br Med J1997; 314: 253–257 .
21.
Rosove MH , Tabsh K , Wasserstrum N , Howard P , Hahn BH , Kalunian KC . Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies . Obstet Gynecol1990; 75: 630–634 .
22.
Kutteh WH . Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone . Am J Obstet Gynecol1996; 174: 1584 –1589 .
23.
Ruffatti A , Orsini A , Di Lenardo L et al. A prospective study of fiftythree consecutive calcium heparin treated pregnancies in patients with antiphospholipid-related fetal loss . Clin Exp Rheumatol1997; 15: 499–505 .
24.
Backos M , Rai R , Baxter N , Chilcott IT , Cohen H , Regan L . Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin . Br J Obstet Gynaecol1999; 106: 102–107 .
25.
Sanson BJ , Lensing AWA , Prins MH et al. Safety of low-molecularweight heparin in pregnancy: a systematic review . Thromb Haemost1999; 81: 668–672 .
26.
Hunt BJ , Doughty HA , Majumdar G et al. Thromboprophylaxis with low molecular weight heparin (fragmin) in high risk pregnancies . Thromb Haemost1997; 77: 39–43 .
27.
Nelson-Piercy C , Letsky E , de Swiet M . Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk . Am J Obstet Gynecol1997; 176: 1062–1068 .
28.
Melissari E , Parker CJ , Wilson NV et al. Use of low molecular weight heparin in pregnancy . Thromb Haemost1992; 68: 652–656 .
29.
Shefras J , Farquharson RG . Bone density studies in pregnant women receiving heparin . Eur J Obstet Gynecol Reprod Biol1996; 65: 171 –174 .
30.
Casele H , Laifer SA . Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium . J Matern Fetal Med2000; 9: 122–125 .
31.
Ruiz-Irastorza G , Khamashta MA , Castellino G , Hughes GRV . Systemic lupus erythematosus . Lancet2001; 357: 1027–1032 .
32.
Farquharson RG , Quenby S , Greaves M . Antiphospholipid syndrome in pregnancy: a controlled treatment trial . J Obstet Gynaecol2001; 21(Suppl 1): S22-S22 (abstract).
